ArticleDiagnostic pathology2023

Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar.

Minna Mutka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.